Arrive AI Announces Fourth Quarter and Full-Year 2025 Results, Highlights Progress Toward Scaling Autonomous Delivery Network
Rhea-AI Summary
Arrive AI (NASDAQ:ARAI) reported full‑year 2025 revenue of $113,250 and a net loss of $12.8 million. Year‑end cash was $2.1 million, with a $10 million post‑year financing draw in January 2026 to strengthen liquidity. Q4 2025 revenue was about $15,000 and Q4 net loss ~$2.7 million. The company highlighted a live deployment with Hancock Health, issuance of its 10th patent, expansion of engineering and platform development (AP5), and new board appointment to support growth.
Positive
- Full‑year revenue of $113,250
- Year‑end cash of $2.1M and $10M post‑year financing draw
- 10th patent issued (Mar 31, 2026) expanding IP protection
- Live Hancock Health deployment validating Arrive Point use in healthcare
Negative
- Net loss widened to $12.8M in 2025 (vs. $4.5M in 2024)
- Operating expenses increased to $10.47M in 2025 from $4.57M
- Convertible notes of $11.0M created $4.14M current note liability and derivative liabilities
News Market Reaction – ARAI
In the Apr 15 session, ARAI declined 38.79%, reflecting a significant negative market reaction. Argus tracked a trough of -27.9% from its starting point during tracking. Our momentum scanner triggered 26 alerts that day, indicating elevated trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous AI Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 06 | Patent issuance | Positive | -19.6% | Tenth U.S. patent expanding shared-use Arrive Points and coordination features. |
| Mar 12 | Conference participation | Positive | -7.8% | Participation in 38th Annual ROTH Conference with investor meetings and presentations. |
| Mar 10 | Product showcase | Positive | -0.9% | Showcase of Arrive Point Network at HIMSS 2026 on AI trail for hospital deliveries. |
| Mar 05 | Deployment white paper | Positive | +0.0% | White paper on Hancock hospital deployment for biospecimen transfers using Arrive Points. |
| Feb 16 | Global expansion | Positive | +1.7% | Showcase of global autonomous logistics ecosystem and new deployments in India and Indiana. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent AI-tag news often saw flat-to-negative reactions, including a -19.55% move on the latest patent win, suggesting investors had been skeptical of non-financial milestones before this earnings release.
Over the last two months, Arrive AI issued multiple AI-focused updates, including a tenth U.S. patent on Apr 6, 2026, participation in conferences like HIMSS 2026 and the India AI Impact Summit, and a white paper on its Hancock hospital deployment. These events, mostly strategic and technical, produced modest to negative price moves (average around -5.32%). Today’s detailed 2025 financials and network-scaling narrative extend that AI theme but add full income statement, balance sheet, and cash flow visibility.
Key Terms
autonomous delivery network technical
chain-of-custody technical
derivative liabilities financial
convertible notes payable financial
restricted stock units financial
operating lease liability financial
embedded derivative financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
INDIANAPOLIS, IN / ACCESS Newswire / April 15, 2026 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network company built around patented, AI-powered Arrive Points™, today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided an update on strategic, operational, and product development progress.
The company will host a conference call and webcast today at 8:30 AM Eastern Time to review results and discuss recent developments. Access details are provided below.
Q4 and Full-Year 2025 Highlights
Q4 Revenue: Approximately
$15,000 , all recurring subscription revenueFull-Year Revenue: Approximately
$113,000 Q4 Net Loss: Approximately
$2.7 million (vs.$1.3 million in Q4 2024)Full-Year Net Loss: Approximately
$12.8 million (vs.$4.5 million in 2024)Year-End Cash: Approximately
$2.1 million Post-Year-End Financing:
$10 million draw from credit facility in January 2026 at favorable terms, strengthening balance sheet
Note: Q4 2025 figures are unaudited and have been derived by subtracting the nine months ended September 30, 2025 from the audited full-year figures included in the Company's Annual Report on Form 10-K. Q4 figures were not separately presented in the 10-K.
CEO Commentary
"Running Arrive AI has been the journey of a lifetime," said Founder and CEO Dan O'Toole. "In 2025 and in recent months, we have focused on the fundamentals: building a strong team, advancing our Arrive Point platform, and proving the technology in real‑world settings like our pilot with Hancock Health. These efforts have strengthened the infrastructure layer we are creating for autonomous logistics and set a solid foundation for our next phase of growth.
O'Toole continued, "We believe there will be a moment where adoption accelerates rapidly. Until then, we are focused on disciplined execution, building the right product, forming the right partnerships, and deploying real-world systems that prove value."
Strategic and Operational Progress
Building the Infrastructure for Autonomous Delivery
Arrive AI continues to focus on solving what it calls "the last inch of the last mile" of autonomous delivery logistics, the secure exchange point between sender, courier, and recipient. The company is developing a network of intelligent delivery endpoints that improve this exchange, and enable:
Secure handoff between humans, robots, and drones
Climate-assisted storage for sensitive goods
Chain-of-custody verification
Interoperability across delivery systems
Intellectual Property Expansion
Arrive AI strengthened its competitive position with the issuance of its 10th patent on March 31, 2026, enabling:
Multi-user access to shared delivery endpoints
Built-in sorting and storage for multiple deliveries
Enhanced coordination across autonomous systems
The company's growing patent portfolio protects key aspects of its platform, including secure delivery endpoints, autonomous handoff, and logistics orchestration.
Real-World Deployment: Hancock Health
A major proof point for Arrive AI's platform is its live deployment with Hancock Health in Indiana, where Arrive Points are being used for autonomous transport of biospecimens between facilities. This deployment has reduced staff walking time, increased operational efficiency, and demonstrated reliable performance in an active healthcare environment, validating the company's ability to integrate into complex, real-world workflows and deliver measurable value.
Partnerships and Ecosystem Strategy
Arrive AI continues to expand its partner ecosystem, working with companies across robotics, logistics, and AI to create an integrated system that works seamlessly with leading technologies in autonomous delivery. The company's strategy focuses on building the network layer, while partners provide delivery hardware and systems.
Current collaborations include:
Integration with autonomous delivery robot provider Ottonomy to ensure robots and the company's Arrive Points communicate effectively, coordinate handoffs, and operate together reliably in live delivery environments.
Participation in the NVIDIA Connect Program, accelerating AI model development and simulation capabilities.
Product Development Acceleration
Following its public listing, Arrive AI significantly expanded its engineering team and consolidated development efforts around its next-generation platform. Key advancements include:
Transition from AP3 to AP5 platform development
Internalization of engineering capabilities to reduce third-party costs
Implementation of AI simulations to support network scaling
Backward compatibility between AP3 and AP5 systems
Leadership Update
The company announced the addition of Mike Fitz, Vice President of Solution Sales and Indirect Channels at T-Mobile for Business, to its Board of Directors. His expertise in telecommunications, 5G, and enterprise networks is expected to support Arrive AI's growth strategy.
Five-Year Strategy
Arrive AI's long-term strategy focuses on scaling its network in stages, starting with early deployments to refine the Arrive Point technology and validate use cases, then expanding into broader enterprise and healthcare applications, and finally, progressing to large-scale manufacturing and deployment. The company ultimately aims to deploy tens to hundreds of thousands of Arrive Points annually, driving network effects across the autonomous logistics ecosystem.
Earnings Call Details
Date: Wednesday, April 15, 2026
Time: 8:30 AM ET
A replay will be available on the company's Investor Relations website following the call.
Portions of the prepared remarks for this earnings call will be delivered using AI-generated voice technology, reflecting Arrive AI's commitment to exploring practical applications of artificial intelligence in business communications.
ARRIVE AI INC.
BALANCE SHEETS
December 31, 2025 | December 31, 2024 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash and cash equivalents | $ | 2,104,004 | $ | 129,318 | ||||
Accounts receivable | 4,975 | - | ||||||
Prepaid expenses | 189,878 | 55,867 | ||||||
Deferred offering costs | - | 427,898 | ||||||
Other current assets | 12,325 | 4,179 | ||||||
Total current assets | 2,311,182 | 617,262 | ||||||
OTHER ASSETS | ||||||||
Property and equipment, net | 514,684 | 95,425 | ||||||
Right of use assets - operating leases | 2,117,284 | - | ||||||
Patents, net of accumulated amortization of | 272,097 | 273,601 | ||||||
Deferred offering costs | 5,650,185 | - | ||||||
Security deposits | 65,633 | 1,500 | ||||||
Total other assets | 8,619,883 | 370,526 | ||||||
TOTAL ASSETS | $ | 10,931,065 | $ | 987,788 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||
CURRENT LIABILITIES | ||||||||
Accounts payable | $ | 183,993 | $ | 1,868,689 | ||||
Accrued expenses | 538,234 | 83,192 | ||||||
Operating lease liability | 392,950 | - | ||||||
Derivative liabilities | 1,460,000 | - | ||||||
Convertible notes payable, net of discount and debt issuance costs of | 4,144,657 | - | ||||||
Note payable | 9,140 | 8,524 | ||||||
Total current liabilities | 6,728,974 | 1,960,405 | ||||||
LONG TERM LIABILITIES | ||||||||
Operating lease liability | 1,725,073 | - | ||||||
Note payable, net of current portion | 1,418 | 10,558 | ||||||
Total long term liabilities | 1,726,491 | 10,558 | ||||||
Total liabilities | 8,455,465 | 1,970,963 | ||||||
Commitments and Contingencies (See Note 18) | - | - | ||||||
STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||
Common stock, | 6,841 | 5,822 | ||||||
Additional paid-in capital | 31,215,698 | 14,984,561 | ||||||
Subscription receivable | - | (53,003 | ) | |||||
Accumulated deficit | (28,746,939 | ) | (15,920,555 | ) | ||||
Total stockholders' equity (deficit) | 2,475,600 | (983,175 | ) | |||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | $ | 10,931,065 | $ | 987,788 | ||||
ARRIVE AI INC.
STATEMENTS OF OPERATIONS
For the Years Ended December 31, 2025 and 2024
2025 | 2024 | |||||||
REVENUE | $ | 113,250 | $ | - | ||||
OPERATING EXPENSES | ||||||||
General and administrative | 9,636,140 | 3,546,520 | ||||||
Research and development | 600,510 | 760,036 | ||||||
Sales and marketing | 229,206 | 266,182 | ||||||
Total operating expenses | 10,465,856 | 4,572,738 | ||||||
OTHER INCOME (EXPENSES) | ||||||||
Interest expense | (686,897 | ) | (4,645 | ) | ||||
Other income | 108,351 | 39,482 | ||||||
Change in fair value of derivative liabilities | 1,516,266 | - | ||||||
Accretion of debt discount | (249,530 | ) | - | |||||
Loss on conversion of convertible notes payable | (3,295,072 | ) | - | |||||
Realized gain on investments | 133,104 | - | ||||||
Total other income (expenses) | (2,473,778 | ) | 34,837 | |||||
NET LOSS BEFORE TAXES | (12,826,384 | ) | (4,537,901 | ) | ||||
PROVISION FOR INCOME TAXES | - | - | ||||||
NET LOSS | $ | (12,826,384 | ) | $ | (4,537,901 | ) | ||
NET LOSS PER SHARE: | ||||||||
Basic and diluted | $ | (0.40 | ) | $ | (0.16 | ) | ||
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING: | ||||||||
Basic and diluted | 32,195,123 | 28,971,543 | ||||||
ARRIVE AI INC.
STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 2025 and 2024
2025 | 2024 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net loss | $ | (12,826,384 | ) | $ | (4,537,901 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||||
Stock-based compensation | 2,503,657 | 1,388,866 | ||||||
Depreciation and amortization | 66,889 | 29,115 | ||||||
Impairment loss | 10,541 | - | ||||||
Operating lease liability - non-cash adjustment | 739 | - | ||||||
Change in fair value of derivative liabilities | (1,516,266 | ) | - | |||||
Loss on conversion of convertible notes payable | 3,295,072 | - | ||||||
Accretion of discount on convertible notes payable | 249,530 | - | ||||||
Accretion of issuance costs on convertible notes payable | 332,160 | - | ||||||
Realized gain on investments | (133,104 | ) | - | |||||
Changes in operating assets and liabilities | ||||||||
(Increase) decrease in | ||||||||
Accounts receivable | (4,975 | ) | - | |||||
Prepaid expenses | (134,011 | ) | (46,724 | ) | ||||
Other current assets | (8,146 | ) | (4,179 | ) | ||||
Security deposits | (64,133 | ) | - | |||||
Increase (decrease) in | ||||||||
Accounts payable | (479,959 | ) | 843,682 | |||||
Accrued expenses | 455,042 | 37,868 | ||||||
Net cash used in operating activities | (8,253,348 | ) | (2,289,273 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital expenditures | (495,185 | ) | (38,155 | ) | ||||
Proceeds from sales of investments | 10,275,473 | - | ||||||
Patent filing costs | - | (76,500 | ) | |||||
Purchase of investments | (10,142,369 | ) | - | |||||
Net cash used in investing activities | (362,081 | ) | (114,655 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Proceeds from sale of common stock, net | 448,057 | 2,643,626 | ||||||
Purchase of treasury stock | (74,743 | ) | - | |||||
Proceeds from the exercise of warrants, net | 573,895 | - | ||||||
Repayments of note payables | (8,524 | ) | (7,954 | ) | ||||
Proceeds from issuance of convertible notes payable | 11,000,000 | - | ||||||
Debt issuance costs | (660,000 | ) | - | |||||
Deferred offering costs | (688,570 | ) | (427,898 | ) | ||||
Net cash provided by financing activities | 10,590,115 | 2,207,774 | ||||||
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 1,974,686 | (196,154 | ) | |||||
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 129,318 | 325,472 | ||||||
CASH AND CASH EQUIVALENTS, END OF YEAR | $ | 2,104,004 | $ | 129,318 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||||||||
Cash paid for: | ||||||||
Interest | $ | 67,555 | $ | 1,635 | ||||
Income taxes | $ | - | $ | - | ||||
SUPPLEMENTAL DISCLOSURE OF NONCASH INFORMATION | ||||||||
Common stock issued as payment of offering costs | $ | 6,927,869 | $ | - | ||||
Common stock issued as settlement of legal expenses | $ | 1,204,737 | $ | - | ||||
Common stock issued for conversion of convertible notes payable | $ | 4,533,980 | $ | - | ||||
Derivative liabilities reclassified as additional paid-in capital upon conversion of convertible notes payable | $ | 1,733,734 | ||||||
Deferred offering costs reclassified as additional paid-in capital upon financing drawdown | $ | 2,394,152 | $ | - | ||||
Cashless exercise of stock options | $ | 6,164 | $ | - | ||||
Right-of-use assets obtained in exchange for lease obligations | $ | 2,216,753 | $ | - | ||||
About Arrive AI
Arrive AI (NASDAQ:ARAI) is building an autonomous delivery network powered by patented, AI-enabled Arrive Points™. The platform enables secure, efficient exchange of goods between people, robots, and drones, providing chain-of-custody control, real-time tracking, and intelligent logistics coordination across last-mile delivery networks.
Media contact:
Kylie Conway at media@arriveai.com
Investor Relations Contact:
Alliance Advisors IR, ARAI.IR@allianceadvisors.com
Cautionary Note Regarding Forward Looking Statements
This news release and statements of Arrive AI's management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "potential", "will", "should", "could", "would", "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI's Registration Statement and other filings for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
SOURCE: Arrive AI Inc.
View the original press release on ACCESS Newswire